Morpheus8 Cool targets patient tolerance on the MAX platform, sharpening competitive positioning against Scarlet and Sofwave.
InMode has launched Morpheus8 Cool on the Morpheus8MAX platform, integrating active cooling into its radiofrequency microneedling system. The move addresses a persistent friction point in RF microneedling adoption: patient comfort during and after treatment.
Cooling is not new to the category—Scarlet Pro and Sofwave both deploy it—but InMode's integration into the MAX ecosystem matters because MAX owners have already invested in the platform's ecosystem and software. The cooling feature works during treatment, not just post-procedure, which can reduce downtime perception and improve patient willingness to book repeat sessions.
Cooling integrated into RF microneedling reduces downtime perception and repeat-booking friction.
For practices already running Morpheus8, the upgrade path and pricing structure will determine uptake. InMode's installed base is substantial, but so is the competitive pressure from VIOL (Scarlet) and Candela (Sofwave). Practices should evaluate whether the cooling addition justifies platform migration or upgrade costs against their current patient satisfaction metrics on standard Morpheus8.
Source: original report ↗
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/mo
Join the owners who run ahead of the industry. Cancel anytime, one click.
